For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, ...
The FDA has approved daratumumab and hyaluronidase-fihj monotherapy as treatment for adults with high-risk smoldering ...
Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated immunotherapies for the treatment of cancer and autoimmune diseases, today ...
MedPage Today on MSN
For Your Patients: Understanding Relapse and What It Means for Your Multiple Myeloma
Multiple myeloma can relapse two or more times, and tends to become more aggressive and more treatment-resistant with each ...
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...
Kimberly Alexander's caregiving experience revealed a lack of awareness and support for multiple myeloma, especially in the ...
MedPage Today on MSN
How to Treat Multiple Myeloma Patients With Renal Impairment
A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...
A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment ...
CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell ...
Completed Equity Offering Resulted in $125 Million in Gross Proceeds, Extending Runway to End of 2028, Beyond Key Value Inflection Points; ...
Neochromosome, Inc., the genome-scale cell engineering subsidiary of lab automation leader, Opentrons Labworks, today announced a turnkey solution for in-house biologics discovery. The platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback